Study on the mechanism of NLRP3 effect on the skeleton of de-ovalized mice

Biochemistry and Biophysics Reports - Tập 35 - Trang 101496 - 2023
Chenchen Yang1, Bing Song1, Lixia Han1, Zhize Gao1
1The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China

Tài liệu tham khảo

Lane, 2000, Osteoporosis, Clin. Orthop. Relat. Res., 139, 10.1097/00003086-200003000-00016 Yu, 2016, Osteoporosis: the result of an 'aged' bone microenvironment, Trends Mol. Med., 22, 641, 10.1016/j.molmed.2016.06.002 Crandall, 2020, Serial bone density measurement and incident fracture risk discrimination in postmenopausal women, JAMA Intern. Med., 180, 1232, 10.1001/jamainternmed.2020.2986 Liu, 2016, GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation, Nat. Commun., 7, 10.1038/ncomms12794 Randell, 2002, Does hormone-replacement therapy prevent fractures in early postmenopausal women?, J. Bone Miner. Res., 17, 528, 10.1359/jbmr.2002.17.3.528 De Villiers, 2015, The role of menopausal hormone therapy in the management of osteoporosis, Climacteric, 18, 19, 10.3109/13697137.2015.1099806 Harvey, 2010, Osteoporosis: impact on health and economics, Nat. Rev. Rheumatol., 6, 99, 10.1038/nrrheum.2009.260 Swanson, 2019, The NLRP3 inflammasome: molecular activation and regulation to therapeutics, Nat. Rev. Immunol., 19, 477, 10.1038/s41577-019-0165-0 Jo, 2016, Molecular mechanisms regulating NLRP3 inflammasome activation, Cell. Mol. Immunol., 13, 148, 10.1038/cmi.2015.95 Kelley, 2019, The NLRP3 inflammasome: an overview of mechanisms of activation and regulation, Int. J. Mol. Sci., 20, 10.3390/ijms20133328 Wang, 2020, The NLRP3 inflammasome: mechanism of action, role in disease and therapies, Mol. Aspect. Med., 76, 10.1016/j.mam.2020.100889 Detzen, 2021, NLRP3 is involved in long bone edification and the maturation of osteogenic cells, J. Cell. Physiol., 236, 4455, 10.1002/jcp.30162 Snouwaert, 2016, An NLRP3 mutation causes arthropathy and osteoporosis in humanized mice, Cell Rep., 17, 3077, 10.1016/j.celrep.2016.11.052 Galluzzi, 2018, Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018, Cell Death Differ., 25, 486, 10.1038/s41418-017-0012-4 Sborgi, 2016, GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death, EMBO J., 35, 1766, 10.15252/embj.201694696 Ran, 2019, Enterococcus faecalis induces apoptosis and pyroptosis of human osteoblastic MG63 cells via the NLRP3 inflammasome, Int. Endod. J., 52, 44, 10.1111/iej.12965 Zhu, 2019, Inhibition of pyroptosis attenuates Staphylococcus aureus-induced bone injury in traumatic osteomyelitis, Ann. Transl. Med., 7, 170, 10.21037/atm.2019.03.40 Xu, 2018, Melatonin suppresses estrogen deficiency-induced osteoporosis and promotes osteoblastogenesis by inactivating the NLRP3 inflammasome, Calcif. Tissue Int., 103, 400, 10.1007/s00223-018-0428-y Lei, 2021, Interleukin-17 induces pyroptosis in osteoblasts through the NLRP3 inflammasome pathway in vitro, Int. Immunopharm., 96, 10.1016/j.intimp.2021.107781 Eghbali-Fatourechi, 2003, Role of RANK ligand in mediating increased bone resorption in early postmenopausal women, J. Clin. Invest., 111, 1221, 10.1172/JCI200317215 Bai, 2004, Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB, Biochem. Biophys. Res. Commun., 314, 197, 10.1016/j.bbrc.2003.12.073 Novack, 2011, Role of NF-κB in the skeleton, Cell Res., 21, 169, 10.1038/cr.2010.159 Redlich, 2012, Inflammatory bone loss: pathogenesis and therapeutic intervention, Nat. Rev. Drug Discov., 11, 234, 10.1038/nrd3669 Agostini, 2004, NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder, Immunity, 20, 319, 10.1016/S1074-7613(04)00046-9 Rovira-Llopis, 2018, Mitochondria, the NLRP3 inflammasome, and sirtuins in type 2 diabetes: new therapeutic targets, Antioxidants Redox Signal., 29, 749, 10.1089/ars.2017.7313 Mcallister, 2018, NLRP3 as a potentially novel biomarker for the management of osteoarthritis, Osteoarthritis Cartilage, 26, 612, 10.1016/j.joca.2018.02.901 Rheinheimer, 2017, Current role of the NLRP3 inflammasome on obesity and insulin resistance: a systematic review, Metabolism, 74, 1, 10.1016/j.metabol.2017.06.002 Szekanecz, 2019, The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout, Arch. Biochem. Biophys., 670, 82, 10.1016/j.abb.2019.01.031 Cline-Smith, 2020, Ovariectomy activates chronic low-grade inflammation mediated by memory T cells, which promotes osteoporosis in mice, J. Bone Miner. Res., 35, 1174, 10.1002/jbmr.3966 Pietschmann, 2016, Immunology of osteoporosis: a mini-review, Gerontology, 62, 128, 10.1159/000431091 Mclean, 2009, Proinflammatory cytokines and osteoporosis, Curr. Osteoporos. Rep., 7, 134, 10.1007/s11914-009-0023-2 Dinarello, 2010, IL-1 family nomenclature, Nat. Immunol., 11, 973, 10.1038/ni1110-973 Percegoni, 2009, Profile of serum IL-1beta and IL-10 shortly after ovariectomy and estradiol replacement in rats, Horm. Metab. Res., 41, 50, 10.1055/s-0028-1087173 Khosla, 2013, Pathogenesis of age-related bone loss in humans, J Gerontol A Biol Sci Med Sci, 68, 1226, 10.1093/gerona/gls163 Tu, 2018, Osteoporosis: a review of treatment options, P t, 43, 92 Granéli, 2014, Novel markers of osteogenic and adipogenic differentiation of human bone marrow stromal cells identified using a quantitative proteomics approach, Stem Cell Res., 12, 153, 10.1016/j.scr.2013.09.009 Elbaz, 2010, Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro, J. Cell Mol. Med., 14, 982, 10.1111/j.1582-4934.2009.00751.x Guo, 2022, FGF19 protects against obesity-induced bone loss by promoting osteogenic differentiation, Biomed. Pharmacother., 146, 10.1016/j.biopha.2021.112524 Liang, 2021, Glycolipid toxicity induces osteogenic dysfunction via the TLR4/S100B pathway, Int. Immunopharm., 97, 10.1016/j.intimp.2021.107792 Zhang, 2021, Necrosulfonamide reverses pyroptosis-induced inhibition of proliferation and differentiation of osteoblasts through the NLRP3/caspase-1/GSDMD pathway, Exp. Cell Res., 405, 10.1016/j.yexcr.2021.112648 Wang, 2017, NLRP3 inflammasome activation in mesenchymal stem cells inhibits osteogenic differentiation and enhances adipogenic differentiation, Biochem. Biophys. Res. Commun., 484, 871, 10.1016/j.bbrc.2017.02.007